Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo2study).

Chalopin T, Vallet N, Arbion F, Barin C, Rault E, Villate A, Eloit M, La Rochelle LD, Foucault A, Ertault M, Dartigeas C, Benboubker L, Estienne MH, Domenech J, Hérault O, Gyan E.

Ann Hematol. 2019 Oct;98(10):2367-2377. doi: 10.1007/s00277-019-03778-9. Epub 2019 Aug 27.

PMID:
31455988
2.

Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma.

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Herfs M, Touzé A, Samimi M, Guyétant S.

Mod Pathol. 2019 Jun 14. doi: 10.1038/s41379-019-0288-7. [Epub ahead of print]

PMID:
31201352
3.

Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study.

Ternant D, Monjanel H, Venel Y, Prunier-Aesch C, Arbion F, Colombat P, Paintaud G, Gyan E.

Br J Clin Pharmacol. 2019 Sep;85(9):2002-2010. doi: 10.1111/bcp.13991. Epub 2019 Jun 26.

PMID:
31112622
4.

Risk scoring system for predicting breast conservation after neoadjuvant chemotherapy.

Ouldamer L, Bendifallah S, Pilloy J, Arbion F, Body G, Brisson C, Lavoué V, Lévêque J, Daraï E.

Breast J. 2019 Jul;25(4):696-701. doi: 10.1111/tbj.13303. Epub 2019 May 7.

PMID:
31066151
5.

Evolution of characteristics of women with endometrial cancer during a 40 years study period.

Lorphelin H, Rossard L, Rua C, Arbion F, Bougnoux P, Body G, Ouldamer L.

J Gynecol Obstet Hum Reprod. 2019 Sep;48(7):489-494. doi: 10.1016/j.jogoh.2019.04.006. Epub 2019 Apr 12.

PMID:
30986541
6.

Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer.

Chas M, Goupille C, Arbion F, Bougnoux P, Pinault M, Jourdan ML, Chevalier S, Ouldamer L.

Breast. 2019 Jun;45:113-117. doi: 10.1016/j.breast.2019.04.001. Epub 2019 Apr 1.

PMID:
30959386
7.

[Influence of hormonal factors on triple-negative breast cancer prognosis].

Weymuller V, Caille A, Diguisto C, Chas M, Jourdan ML, Arbion F, Body G, Ouldamer L.

Gynecol Obstet Fertil Senol. 2019 May;47(5):471-477. doi: 10.1016/j.gofs.2019.03.006. Epub 2019 Mar 11. French.

PMID:
30872189
8.

[Prognosis impact of breast cancer adjuvant radiotherapy delay].

Lesage M, Pilloy J, Fleurier C, Cirier J, Jourdan ML, Arbion F, Body G, Ouldamer L.

Gynecol Obstet Fertil Senol. 2019 Jun;47(6):516-521. doi: 10.1016/j.gofs.2019.03.001. Epub 2019 Mar 6. French.

PMID:
30851415
9.

[Predictive factors of concordance (5mm threshold) between MRI and histological sizes of invasive lobular breast cancer].

Gest R, Cayet S, Arbion F, Vildé A, Body G, Ouldamer L.

Gynecol Obstet Fertil Senol. 2019 Mar;47(3):291-296. doi: 10.1016/j.gofs.2019.01.004. Epub 2019 Jan 25. French.

PMID:
30686731
10.

Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas.

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Touzé A, Samimi M, Guyétant S.

Mod Pathol. 2019 Apr;32(4):499-510. doi: 10.1038/s41379-018-0155-y. Epub 2018 Oct 22.

PMID:
30349028
11.

Management and prognosis of pure primary squamous cell carcinoma of the breast.

Benoist P, Mureau A, Joueidi Y, Arbion F, Vilde A, Body G, Michenet P, Leveque J, Ouldamer L.

J Gynecol Obstet Hum Reprod. 2018 Sep;47(7):275-280. doi: 10.1016/j.jogoh.2018.06.007. Epub 2018 Jun 27.

PMID:
29959086
12.

[Osteochondroplastic tracheobronchopathy: About three cases].

Ferreira M, Morel H, Dixmier A, Arbion F, Marchand-Adam S.

Rev Mal Respir. 2018 Sep;35(7):738-744. doi: 10.1016/j.rmr.2017.10.668. Epub 2018 Jun 23. French.

PMID:
29945809
13.

Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer.

Ouldamer L, Chas M, Arbion F, Body G, Cirier J, Ballester M, Bendifallah S, Daraï E.

Surg Oncol. 2018 Jun;27(2):158-165. doi: 10.1016/j.suronc.2018.02.003. Epub 2018 Feb 21. Review.

PMID:
29937166
14.

All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excision.

Ouldamer L, Poisson E, Arbion F, Bonneau C, Vildé A, Body G, Michenet P.

Breast. 2018 Aug;40:4-9. doi: 10.1016/j.breast.2018.03.012. Epub 2018 Apr 14.

PMID:
29665448
15.

Axillary lymph node metastases from unknown primary: A French multicentre study.

Ouldamer L, Cayrol M, Vital M, Fièvre C, Druelles M, Arbion F, Body G, Lévêque J, Fritel X.

Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:103-107. doi: 10.1016/j.ejogrb.2018.02.021. Epub 2018 Feb 23.

PMID:
29518639
16.

[Presentation and outcome of breast cancer under 40 years - A French monocentric study].

Fleurier C, Pilloy J, Chas M, Cirier J, Jourdan ML, Arbion F, Body G, Ouldamer L.

Gynecol Obstet Fertil Senol. 2018 Feb;46(2):105-111. doi: 10.1016/j.gofs.2017.12.012. Epub 2018 Feb 1. French.

PMID:
29361410
17.

Clinicopathologic predictors of lymph node metastasis in breast cancer patients according to molecular subtype.

Chas M, Boivin L, Arbion F, Jourdan ML, Body G, Ouldamer L.

J Gynecol Obstet Hum Reprod. 2018 Jan;47(1):9-15. doi: 10.1016/j.jogoh.2017.10.008. Epub 2017 Nov 11.

PMID:
29104006
18.

[Impact of pathological complete response to neoadjuvant chemotherapy in invasive breast cancer according to molecular subtype].

Cirier J, Body G, Jourdan ML, Bedouet L, Fleurier C, Pilloy J, Arbion F, Ouldamer L.

Gynecol Obstet Fertil Senol. 2017 Oct;45(10):535-544. doi: 10.1016/j.gofs.2017.08.002. Epub 2017 Sep 20. French.

PMID:
28939364
19.

[Predictive factors of conservative breast surgery after neoadjuvant chemotherapy for breast cancer].

Pilloy J, Fleurier C, Chas M, Bédouet L, Jourdan ML, Arbion F, Body G, Ouldamer L.

Gynecol Obstet Fertil Senol. 2017 Sep;45(9):466-471. doi: 10.1016/j.gofs.2017.07.003. Epub 2017 Aug 30. French.

PMID:
28869182
20.

Primary solitary plasmacytoma of the liver - successful treatment with fractionated stereotactic radiotherapy (Cyberknife®): a case report.

Chalopin T, Barillot I, Biny JP, Arbion F, Besson M, Santiago-Ribeiro M, Piver E, Herault O, Gyan E, Benboubker L.

J Med Case Rep. 2017 Jul 18;11(1):193. doi: 10.1186/s13256-017-1358-4.

21.

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadié M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, Rousselet MC, Brière J, Charlotte F, Chassagne-Clement C, Rousset T, Xerri L, Moreau A, Martin A, Damotte D, Dartigues P, Soubeyran I, Peoch M, Dechelotte P, Michiels JF, de Mascarel A, Berger F, Bossard C, Arbion F, Quintin-Roué I, Picquenot JM, Patey M, Fabre B, Sevestre H, Le Naoures C, Chenard-Neu MP, Bastien C, Thiebault S, Martin L, Delage M, Filleron T, Salles G, Molina TJ, Delsol G, Brousset P, Gaulard P.

J Clin Oncol. 2017 Jun 20;35(18):2008-2017. doi: 10.1200/JCO.2016.71.2083. Epub 2017 May 1.

PMID:
28459613
22.

[Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].

Brisson C, Diguisto C, Vildé A, Body G, Arbion F, Leveque J, Ouldamer L.

J Gynecol Obstet Hum Reprod. 2017 Feb;46(2):147-154. doi: 10.1016/j.jogoh.2016.11.003. Epub 2017 Jan 30. French.

PMID:
28403971
23.

[Outcomes of patients with breast cancer in function of their body mass index].

Boivin L, Diguisto C, Chas M, Bédouet L, Etienne C, Arbion F, Body G, Ouldamer L.

Gynecol Obstet Fertil Senol. 2017 Apr;45(4):215-223. doi: 10.1016/j.gofs.2017.02.008. Epub 2017 Mar 27. French.

PMID:
28359803
24.

Is there a justification for hysterectomy in patients with borderline ovarian tumors?

Ouldamer L, Lacoste C, Cormier B, Arbion F, Marret H, Jallais L, Fignon A, Body G.

Surg Oncol. 2016 Mar;25(1):1-5. doi: 10.1016/j.suronc.2015.11.004. Epub 2015 Nov 12. Review.

PMID:
26979634
25.

N-3 Polyunsaturated Fatty Acids of Marine Origin and Multifocality in Human Breast Cancer.

Ouldamer L, Goupille C, Vildé A, Arbion F, Body G, Chevalier S, Cottier JP, Bougnoux P.

PLoS One. 2016 Jan 26;11(1):e0147148. doi: 10.1371/journal.pone.0147148. eCollection 2016.

26.

A CASE OF CHORIORETINOPATHY AS FIRST MANIFESTATION OF HODGKIN'S LYMPHOMA.

Doyen H, Monjanel H, Regina S, Magnant J, Arbion F, Lissandre S, Gyan E, Le Lez ML.

Retin Cases Brief Rep. 2016 Summer;10(3):239-43. doi: 10.1097/ICB.0000000000000240.

PMID:
26771860
27.

Breastlike vulvar carcinoma.

Serre E, Arbion F, Marret H, Body G, Ouldamer L.

Gynecol Obstet Fertil. 2016 Jan;44(1):74-5. doi: 10.1016/j.gyobfe.2015.11.013. Epub 2015 Dec 22. No abstract available.

PMID:
26725883
28.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P.

Haematologica. 2015 Sep;100(9):e361-4. doi: 10.3324/haematol.2015.126300. Epub 2015 Jun 4. No abstract available.

30.

What should be the width of radiological margin to optimize resection of non-palpable invasive or in situ ductal carcinoma?

Ouldamer L, Lechaux E, Arbion F, Body G, Vildé A.

Breast. 2014 Dec;23(6):889-93. doi: 10.1016/j.breast.2014.10.001. Epub 2014 Oct 23.

PMID:
25456102
32.

[Bartholin's gland carcinoma].

Chraibi Z, Hebert T, Body G, Arbion F, Ouldamer L.

Gynecol Obstet Fertil. 2014 Jul-Aug;42(7-8):540-2. doi: 10.1016/j.gyobfe.2014.05.008. Epub 2014 Jun 18. French.

PMID:
24951185
33.

Recurrent primary cutaneous mucinous carcinoma with neuroendocrine differentiation: case report and review of the literature.

Miquelestorena-Standley E, Dujardin F, Arbion F, Touzé A, Machet L, Velut S, Guyétant S.

J Cutan Pathol. 2014 Aug;41(8):686-91. doi: 10.1111/cup.12347. Epub 2014 Apr 9. Review.

PMID:
24641329
34.

Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years' experience in a single centre.

Radesi-Sarghi S, Arbion F, Dartigeas C, Delain M, Benboubker L, Hérault O, Colombat P, Gyan E.

Ann Hematol. 2014 Jan;93(1):147-156. Epub 2013 Nov 14.

PMID:
24232218
35.

Novel use of contrast-enhanced sonography in the diagnosis of central uterine necrosis following embolization for postpartum hemorrhage.

Desille H, Ouldamer L, Bleuzen A, Arbion F, Herbreteau D, Marret H.

J Ultrasound Med. 2013 Oct;32(10):1869-76. doi: 10.7863/ultra.32.10.1869.

PMID:
24065269
36.

Risk of incidental finding of endometrial cancer at the time of hysterectomy for benign condition.

Ouldamer L, Rossard L, Arbion F, Marret H, Body G.

J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):131-5. doi: 10.1016/j.jmig.2013.08.002. Epub 2013 Aug 17.

PMID:
23962573
37.

Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.

Chantôme A, Potier-Cartereau M, Clarysse L, Fromont G, Marionneau-Lambot S, Guéguinou M, Pagès JC, Collin C, Oullier T, Girault A, Arbion F, Haelters JP, Jaffrès PA, Pinault M, Besson P, Joulin V, Bougnoux P, Vandier C.

Cancer Res. 2013 Aug 1;73(15):4852-61. doi: 10.1158/0008-5472.CAN-12-4572. Epub 2013 Jun 17.

38.

Bartholin's gland carcinoma: epidemiology and therapeutic management.

Ouldamer L, Chraibi Z, Arbion F, Barillot I, Body G.

Surg Oncol. 2013 Jun;22(2):117-22. doi: 10.1016/j.suronc.2013.02.004. Epub 2013 Mar 14. Review.

PMID:
23499140
39.

Evaluation of the two intraoperative examination methods for sentinel lymph node assessment: a multicentric and retrospective study on more than 2,000 nodes.

Arlicot C, Louarn AL, Arbion F, Leveque J, Lorand S, Kinn J, Chaze B, Garrigue A, Body G.

Anticancer Res. 2013 Mar;33(3):1045-52.

PMID:
23482780
40.

Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.

Ouldamer L, Arbion F, Balagny A, Fourquet F, Marret H, Body G.

Breast. 2013 Oct;22(5):787-92. doi: 10.1016/j.breast.2013.02.004. Epub 2013 Mar 7.

PMID:
23473772
41.

[The impact of therapeutic management on survival of elderly women with endometrial cancer].

Ouldamer L, Duquesne M, Arbion F, Barillot I, Marret H, Body G.

Gynecol Obstet Fertil. 2012 Dec;40(12):759-64. doi: 10.1016/j.gyobfe.2012.07.015. Epub 2012 Sep 18. French.

PMID:
22995058
42.

[About a case of rhabdomyosarcoma with an aberrant expression of epithelial markers: a cause of misdiagnosis].

Cormier B, Arbion F, Rousselot C, Gaillardin L, de Pinieux G.

Ann Pathol. 2012 Jun;32(3):224-8. doi: 10.1016/j.annpat.2012.01.004. Epub 2012 May 16. French.

PMID:
22748343
43.

Immunophenotypic and genomic characterization of papillary carcinomas of the breast.

Duprez R, Wilkerson PM, Lacroix-Triki M, Lambros MB, MacKay A, A'Hern R, Gauthier A, Pawar V, Colombo PE, Daley F, Natrajan R, Ward E, MacGrogan G, Arbion F, Michenet P, Weigelt B, Vincent-Salomon A, Reis-Filho JS.

J Pathol. 2012 Feb;226(3):427-441. doi: 10.1002/path.3032. Epub 2011 Dec 9.

44.

[Intravascular lymphoma: report of two autopsic cases, literature review].

Rousselot-Denis C, Arbion F, Jaunas M, Rousselet MC, Guyetant S.

Ann Pathol. 2011 Aug;31(4):320-4. doi: 10.1016/j.annpat.2011.05.012. Epub 2011 Jul 7. Review. French.

PMID:
21839361
45.

Thyroid gland invasion in laryngopharyngeal squamous cell carcinoma: prevalence, endoscopic and CT predictors.

Gaillardin L, Beutter P, Cottier JP, Arbion F, Morinière S.

Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Feb;129(1):1-5. doi: 10.1016/j.anorl.2011.04.002. Epub 2011 Jul 27.

46.

[Mucocele-like lesions of the breast: management after diagnosis on ultrasound guided core biopsy or stereotactic vacuum-assisted biopsy].

Ouldamer L, Body G, Arbion F, Avigdor S, Michenet P.

Gynecol Obstet Fertil. 2010 Jul-Aug;38(7-8):455-9. doi: 10.1016/j.gyobfe.2010.04.003. Epub 2010 Jun 4. French.

PMID:
20605510
47.

Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.

Blouin P, Yvert M, Arbion F, Pagnier A, Emile JF, Eitenschenck L, Machet MC, Plantaz D, Colombat P, Alla CA, Donadieu J.

Pediatr Blood Cancer. 2010 Oct;55(4):757-60. doi: 10.1002/pbc.22629. Review.

PMID:
20589639
48.

Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.

Monjanel H, Hourioux C, Arbion F, Colombat P, Lissandre S, Regner MP, Senecal D.

Leuk Res. 2010 Aug;34(8):e197-9. doi: 10.1016/j.leukres.2010.01.019. Epub 2010 Mar 7. No abstract available.

PMID:
20211489
49.

[Endometrial and endocervical lesions associated with pseudomyxoma peritonei: a case report].

Samet I, Cormier B, Mowlawi H, Philippe A, Arbion F, Fétissof F.

Ann Pathol. 2009 Jun;29(3):233-7. doi: 10.1016/j.annpat.2009.02.017. Epub 2009 Jun 12. French.

PMID:
19619832
50.

[Mullerian "inclusions" within an intramammary lymph node].

Rousselot C, Chapiron C, Blechet C, Arbion F, Fetissof F.

Ann Pathol. 2006 Jun;26(3):204-6. French.

PMID:
17127851

Supplemental Content

Loading ...
Support Center